Group One Trading’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,286
Closed -$459K 9058
2025
Q2
$459K Sell
50,286
-7,098
-12% -$52.2K ﹤0.01% 3503
2025
Q1
$456K Buy
+57,384
New +$420K ﹤0.01% 3187
2024
Q3
Sell
-399,305
Closed -$3.66M 7281
2024
Q2
$4.34M Buy
399,305
+362,916
+997% +$4.65M 0.02% 897
2024
Q1
$682K Buy
36,389
+34,408
+1,737% +$794K ﹤0.01% 2439
2023
Q4
$42.9K Sell
1,981
-35,958
-95% -$713K ﹤0.01% 5183
2023
Q3
$781K Buy
37,939
+25,527
+206% +$737K ﹤0.01% 2504
2023
Q2
$584K Sell
12,412
-2,029
-14% -$101K ﹤0.01% 2859
2023
Q1
$606K Sell
14,441
-5,698
-28% -$245K ﹤0.01% 2581
2022
Q4
$768K Sell
20,139
-1,333
-6% -$50.9K ﹤0.01% 2648
2022
Q3
$841K Buy
21,472
+6,514
+44% +$252K ﹤0.01% 2754
2022
Q2
$483K Buy
14,958
+14,484
+3,056% +$485K ﹤0.01% 3459
2022
Q1
$16K Sell
474
-1,875
-80% -$70.5K ﹤0.01% 6916
2021
Q4
$100K Sell
2,349
-7,000
-75% -$293K ﹤0.01% 5728
2021
Q3
$414K Sell
9,349
-80,926
-90% -$3.71M ﹤0.01% 4404
2021
Q2
$5.13M Buy
90,275
+84,212
+1,389% +$5.95M 0.01% 1666
2021
Q1
$454K Buy
+6,063
New +$497K ﹤0.01% 4155
2020
Q4
Sell
-10,898
Closed -$803K 6939
2020
Q3
$666K Sell
10,898
-16,185
-60% -$820K ﹤0.01% 2592
2020
Q2
$1.13M Sell
27,083
-6,983
-20% -$253K 0.01% 1917
2020
Q1
$978K Buy
+34,066
New +$1.97M 0.01% 1544
2019
Q4
Sell
-3,627
Closed -$446K 5544
2019
Q3
$509K Buy
+3,627
New +$607K ﹤0.01% 2318
2019
Q1
Sell
-8,166
Closed -$1.18M 5292
2018
Q4
$782K Buy
+8,166
New +$935K 0.01% 1687
2017
Q4
Sell
-1,823
Closed -$177K 5179
2017
Q3
$114K Sell
1,823
-5,589
-75% -$439K ﹤0.01% 3150
2017
Q2
$590K Sell
7,412
-2,018
-21% -$146K 0.01% 1851
2017
Q1
$670K Buy
9,430
+8,090
+604% +$474K 0.01% 1648
2016
Q4
$68K Buy
+1,340
New +$63.2K ﹤0.01% 3071
2016
Q3
Sell
-5,700
Closed -$232K 4866
2016
Q2
$172K Buy
5,700
+5,100
+850% +$170K ﹤0.01% 2505
2016
Q1
$19K Buy
+600
New +$21.1K ﹤0.01% 3778
2015
Q4
Sell
-5,000
Closed -$248K 5038
2015
Q3
$212K Buy
5,000
+2,745
+122% +$169K ﹤0.01% 2459
2015
Q2
$165K Buy
+2,255
New +$145K ﹤0.01% 2674

Other funds holding SAGE